| scholarly article | Q13442814 |
| P50 | author | Roxana Mehran | Q43249705 |
| George D Dangas | Q63256402 | ||
| Akiko Maehara | Q92345727 | ||
| Gary S Mintz | Q96436990 | ||
| Jeffrey W Moses | Q96952468 | ||
| Giora Weisz | Q114304178 | ||
| Usman Baber | Q114304186 | ||
| Diaa A Hakim | Q114304464 | ||
| Amala P Chirumamilla | Q114444092 | ||
| Sunil Kanwal | Q114444093 | ||
| Robert T Pyo | Q114516053 | ||
| P2093 | author name string | Ning Guo | |
| Martin Fahy | |||
| Ahmed Hassanin | |||
| Jason C Kovacic | |||
| P2860 | cites work | The CXC-chemokine platelet factor 4 promotes monocyte survival and induces monocyte differentiation into macrophages | Q22253155 |
| Antiplatelet therapy for ischemic heart disease | Q28166775 | ||
| Clopidogrel resistance is associated with increased risk of recurrent atherothrombotic events in patients with acute myocardial infarction | Q28168881 | ||
| Platelet reactivity in patients and recurrent events post-stenting: results of the PREPARE POST-STENTING Study | Q28193340 | ||
| Clopidogrel for coronary stenting: response variability, drug resistance, and the effect of pretreatment platelet reactivity | Q28196405 | ||
| Resistance to thienopyridines: clinical detection of coronary stent thrombosis by monitoring of vasodilator-stimulated phosphoprotein phosphorylation | Q28196513 | ||
| Drug insight: Clopidogrel nonresponsiveness | Q28198683 | ||
| Evidence that pre-existent variability in platelet response to ADP accounts for 'clopidogrel resistance' | Q28200552 | ||
| Increased risk in patients with high platelet aggregation receiving chronic clopidogrel therapy undergoing percutaneous coronary intervention: is the current antiplatelet therapy adequate? | Q28218910 | ||
| 2009 Focused Updates: ACC/AHA Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction and ACC/AHA/SCAI Guidelines on Percutaneous Coronary Intervention | Q28265917 | ||
| Regulation of platelet functions by P2 receptors | Q28290720 | ||
| Circulating activated platelets exacerbate atherosclerosis in mice deficient in apolipoprotein E. | Q30310323 | ||
| Stat3-dependent acute Rantes production in vascular smooth muscle cells modulates inflammation following arterial injury in mice | Q33559676 | ||
| Impact of platelet reactivity on clinical outcomes after percutaneous coronary intervention. A collaborative meta-analysis of individual participant data | Q34060015 | ||
| Platelets in atherothrombosis | Q34986345 | ||
| Role of platelets in coronary thrombosis and reperfusion of ischemic myocardium | Q35666909 | ||
| Platelets and chemokines in atherosclerosis: partners in crime | Q36085380 | ||
| Platelets in inflammation and atherogenesis. | Q36328825 | ||
| Flow effects on coagulation and thrombosis | Q36495020 | ||
| Platelet function monitoring in patients with coronary artery disease | Q36990868 | ||
| Platelet-monocyte interactions--a dangerous liaison linking thrombosis, inflammation and atherosclerosis | Q37239719 | ||
| Molecular and functional interactions among monocytes, platelets, and endothelial cells and their relevance for cardiovascular diseases | Q37307308 | ||
| Antiplatelet therapy in diabetes: efficacy and limitations of current treatment strategies and future directions | Q37428365 | ||
| Bedside evaluation of thienopyridine antiplatelet therapy | Q37487318 | ||
| Cellular senescence, vascular disease, and aging: part 2 of a 2-part review: clinical vascular disease in the elderly | Q37871249 | ||
| Standard- vs high-dose clopidogrel based on platelet function testing after percutaneous coronary intervention: the GRAVITAS randomized trial | Q38493350 | ||
| A critical role of platelet adhesion in the initiation of atherosclerotic lesion formation | Q41824616 | ||
| Vascular calcification: harder than it looks | Q41839703 | ||
| High residual platelet reactivity after clopidogrel: extent of coronary atherosclerosis and periprocedural myocardial infarction in patients with stable angina undergoing percutaneous coronary intervention | Q43175056 | ||
| Transient interaction of activated platelets with endothelial cells induces expression of monocyte-chemoattractant protein-1 via a p38 mitogen-activated protein kinase mediated pathway. Implications for atherogenesis | Q43512545 | ||
| Individual variations of platelet inhibition after loading doses of clopidogrel | Q44148275 | ||
| Flow cytometric analysis of intraplatelet VASP phosphorylation for the detection of clopidogrel resistance in patients with ischemic cardiovascular diseases | Q45213002 | ||
| Prospective evaluation of on-clopidogrel platelet reactivity over time in patients treated with percutaneous coronary intervention relationship with gene polymorphisms and clinical outcome. | Q45947797 | ||
| Antiplatelet drugs: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). | Q46522937 | ||
| Platelet adhesion via glycoprotein IIb integrin is critical for atheroprogression and focal cerebral ischemia: an in vivo study in mice lacking glycoprotein IIb. | Q46652724 | ||
| Healed plaque ruptures and sudden coronary death: evidence that subclinical rupture has a role in plaque progression. | Q52542159 | ||
| Platelet degranulation is associated with progression of intima-media thickness of the common carotid artery in patients with diabetes mellitus type 2. | Q52939233 | ||
| Dilation-Dependent Activation of Platelets and Prothrombin in Human Thoracic Ascending Aortic Aneurysm | Q61866616 | ||
| Coronary artery calcification: pathophysiology, epidemiology, imaging methods, and clinical implications. A statement for health professionals from the American Heart Association. Writing Group | Q71493661 | ||
| Platelets induce alterations of chemotactic and adhesive properties of endothelial cells mediated through an interleukin-1-dependent mechanism. Implications for atherogenesis | Q73224126 | ||
| Coronary calcification: insights from sudden coronary death victims | Q73685716 | ||
| Platelet P-selectin facilitates atherosclerotic lesion development | Q78654773 | ||
| Platelet factor 4 localization in carotid atherosclerotic plaques: correlation with clinical parameters | Q79339926 | ||
| Impact of gender and age on in vivo virtual histology-intravascular ultrasound imaging plaque characterization (from the global Virtual Histology Intravascular Ultrasound [VH-IVUS] registry) | Q83752894 | ||
| P433 | issue | 5 | |
| P921 | main subject | clopidogrel | Q410237 |
| intravascular ultrasound | Q1671577 | ||
| atherosclerosis | Q12252367 | ||
| P304 | page(s) | 540-549 | |
| P577 | publication date | 2012-05-01 | |
| P1433 | published in | JACC: Cardiovascular Imaging | Q15816252 |
| P1476 | title | High platelet reactivity on clopidogrel therapy correlates with increased coronary atherosclerosis and calcification: a volumetric intravascular ultrasound study | |
| P478 | volume | 5 |
| Q52870183 | Adhesion and activation of platelets from subjects with coronary artery disease and apparently healthy individuals on biomaterials. |
| Q36720281 | Association between insulin receptor substrate-1 polymorphisms and high platelet reactivity with clopidogrel therapy in coronary artery disease patients with type 2 diabetes mellitus |
| Q55258177 | Association of serum levels of lipoprotein A-I and lipoprotein A-I/A-II with high on-treatment platelet reactivity in patients with ST-segment elevation myocardial infarction. |
| Q91526722 | Clopidogrel plus Aspirin Use is Associated with Worse Long-Term Outcomes, but Aspirin Use Alone is Safe in Patients with Vasospastic Angina: Results from the VA-Korea Registry, A Prospective Multi-Center Cohort |
| Q43992016 | Computed tomography angiography intraluminal filling defect is predictive of internal carotid artery free-floating thrombus |
| Q26829251 | Consensus and update on the definition of on-treatment platelet reactivity to adenosine diphosphate associated with ischemia and bleeding |
| Q30419699 | Coronary artery calcification is inversely related to body morphology in patients with significant coronary artery disease: a three-dimensional intravascular ultrasound study |
| Q47833058 | D-dimer levels predict ischemic and hemorrhagic outcomes after acute myocardial infarction: a HORIZONS-AMI biomarker substudy |
| Q45824389 | Dynamic changes and associated factors of clopidogrel resistance in patients after cerebral infarction |
| Q38694069 | Effects of P2Y12 receptor antagonists beyond platelet inhibition--comparison of ticagrelor with thienopyridines |
| Q47161058 | Factors related to on-treatment platelet aggregation assessed by multiple electrode aggregometry in percutaneous coronary intervention patients on clopidogrel and aspirin. |
| Q52932474 | High Residual Collagen-Induced Platelet Reactivity Predicts Development of Restenosis in the Superficial Femoral Artery After Percutaneous Transluminal Angioplasty in Claudicant Patients. |
| Q26824850 | High residual platelet reactivity on clopidogrel: its significance and therapeutic challenges overcoming clopidogrel resistance |
| Q40437905 | Impact of Calcified Target Lesions on the Outcome of Percutaneous Coronary Intervention for Acute Coronary Syndrome: Insights From the BASE ACS Trial. |
| Q90440684 | Impact of gender on immature platelet count and its relationship with coronary artery disease |
| Q37694929 | Influence of Cyp2c19*2 Gene Variant on Therapeutic Response During Clopidogrel Treatment in Patients with Carotid Artery Stenosis |
| Q34283808 | Is there attenuation of benefit of invasive therapy in patients with chronic kidney disease? Results from randomized trials and registry data |
| Q39187857 | Serial clopidogrel dose adjustment after platelet function testing improves outcome of acute coronary syndrome patients undergoing percutaneous coronary intervention with high on-treatment platelet reactivity |
| Q39138783 | Serum Gamma-glutamyltransferase Levels Predict the Progression of Coronary Artery Calcification in Adults With Type 2 Diabetes Mellitus |
| Q50479261 | The relationship between complete blood count parameters and Fontaine's Stages in patients with peripheral arterial disease. |
| Q33906710 | Therapeutic approaches to drug targets in atherosclerosis |
Search more.